Skip to content
  • Home
  • About
  • Products
    • Abramit 250
    • Abramit 500
    • Acamit
    • Capebax
    • Crizomits
    • Dasomit 50
    • Dasomit 100
    • Erlomits
    • Fludamits
    • Imatrex
    • Leucovex
    • Mexotrex1000
    • Mitsigem
    • Mitsigem200
    • Mitsogef
    • Mitsotrex 500
    • Mitsotrex50
    • Paclomits 30
    • Paclomits 100
    • Paclomits 260
    • Pazomit 200
    • Pazomit 400
    • Regomit
  • Blog
  • Contact
Oncolife.cdr
Enquiry

Day: October 1, 2026

How Abiraterone Acetate 250mg Benefits Prostate Cancer Patients and Why That Drives Franchise Demand

Abiraterone Acetate 250mg

Prostate cancer is one of the most common cancers diagnosed in men and a common cause of cancer death in men aged over 50. Treatment options vary with the stage of the cancer and may involve hormone therapy, surgery, radiotherapy, chemotherapy, or other targeted treatments. In hormone-based treatments, abiraterone acetate 250 mg is an important […]

MITS Oncology specializes in oncology and formulations focused on modern cancer treatment.

Facebook Instagram Linkedin

Our Products

  • Abramit 250
  • Abramit 500
  • Acamit
  • Capebax
  • Crizomits
  • Dasomit 50
  • Dasomit 100
  • Erlomits
  • Fludamits
  • Imatrex
  • Leucovex
  • Mexotrex1000
  • Mitsigem
  • Mitsigem200
  • Mitsogef
  • Mitsotrex 500
  • Mitsotrex50
  • Paclomits 30
  • Paclomits 100
  • Paclomits 260
  • Pazomit 200
  • Pazomit 400
  • Regomit

Contact Us

  • +91 90413 28328
  • +91 98759 15603
  • +91 70874 04024
  • info@mitsoncology.com
  • Plot No. 331, Phase 1 Industrial Area, Panchkula, Haryana - 134113.
  • Privacy Policy
  • Terms & Conditions
  • Blog

© 2026 Mits Oncolife. All rights reserved. | Powered ♥ by: WebClixs

    Request a Quote